UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 257

Sortiert nach

Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases

European journal of internal medicine, 2013-07, Vol.24 (5), p.385-392

2013

Link zum Volltext

Verfügbarkeit prüfen

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2011, Vol.9 (1), p.30-35

2011

Link zum Volltext

Verfügbarkeit prüfen

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials

Radiology, 2002-07, Vol.224 (1), p.47

2002

Link zum Volltext

Verfügbarkeit prüfen

Mesalazine for the treatment of inflammatory bowel disease

Expert opinion on pharmacotherapy, 2013-08, Vol.14 (12), p.1669-1678

2013

Link zum Volltext

Verfügbarkeit prüfen

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease

Digestive and liver disease, 2017-06, Vol.49 (6), p.604-617

2017

Link zum Volltext

Verfügbarkeit prüfen

Occult hepatitis B and infliximab‐induced HBV reactivation

Inflammatory bowel diseases, 2007-04, Vol.13 (4), p.508-509

2007

Link zum Volltext

Verfügbarkeit prüfen

Could JC virus provoke metastasis in colon cancer?

World journal of gastroenterology : WJG, 2014-11, Vol.20 (42), p.15745-15749

2014

Link zum Volltext

Verfügbarkeit prüfen

Is 5-ASA still the treatment of choice for ulcerative colitis?

Current drug targets, 2011-09, Vol.12 (10), p.1396

2011

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal lesions associated with spondyloarthropathies

World journal of gastroenterology : WJG, 2009-05, Vol.15 (20), p.2443-2448

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures

Digestive and liver disease, 2011-02, Vol.43 (2), p.121-125

2011

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study

Journal of Crohn's and colitis, 2012-07, Vol.6 (6), p.681-686

2012

Link zum Volltext

Verfügbarkeit prüfen

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

Digestive and liver disease, 2018-12, Vol.50 (12), p.1292-1298

2018

Link zum Volltext

Verfügbarkeit prüfen

Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis

World journal of gastroenterology : WJG, 2011-02, Vol.17 (5), p.633-638

2011

Link zum Volltext

Verfügbarkeit prüfen

Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: Don't forget the role of cyclosporin

Inflammatory bowel diseases, 2012-08, Vol.18 (8), p.E1594-E1595

2012

Link zum Volltext

Verfügbarkeit prüfen

Methodology for high-quality studies on course and prognosis of inflammatory bowel disease

World journal of gastroenterology : WJG, 2012-08, Vol.18 (29), p.3800-3805

2012

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus and inflammatory bowel disease: is there a link?

World journal of gastroenterology : WJG, 2006-08, Vol.12 (30), p.4813

2006

Link zum Volltext

Verfügbarkeit prüfen

Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome

Gastroenterology research and practice, 2012-01, Vol.2012, p.486067-11

2012

Link zum Volltext

Verfügbarkeit prüfen

Anti-interleukin-12 and anti-interleukin-23 agents in Crohn's disease

Expert opinion on biological therapy, 2019-02, Vol.19 (2), p.89-98

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized controlled trials in perianal Crohn's disease

Reviews on recent clinical trials, 2012-11, Vol.7 (4), p.297

2012

Link zum Volltext

Verfügbarkeit prüfen

Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials

The American journal of gastroenterology, 2009-02, Vol.104 (2), p.514-524

2009

Link zum Volltext

Verfügbarkeit prüfen

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities

Clinical gastroenterology and hepatology, 2019-02, Vol.17 (3), p.571-572

2019

Link zum Volltext

Verfügbarkeit prüfen

Intestinal Permeability and Genetic Determinants in Patients, First-Degree Relatives, and Controls in a High-Incidence Area of Crohn's Disease in Southern Italy

The American journal of gastroenterology, 2005-12, Vol.100 (12), p.2730-2736

2005

Link zum Volltext

Verfügbarkeit prüfen

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease

World journal of gastroenterology : WJG, 2014-08, Vol.20 (29), p.9675-9690

2014

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab in steroid-dependent Crohnʼs disease patients: Prognostic factors for clinical benefit

Inflammatory bowel diseases, 2012-05, Vol.18 (5), p.826-831

2012

Link zum Volltext

Verfügbarkeit prüfen

Smoking habits and recurrence in Crohn's disease

Gastroenterology (New York, N.Y. 1943), 1994-03, Vol.106 (3), p.643-648

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(171)
Humans
(149)
Gastroenterology & Hepatology
(96)
Female
(83)
Male
(79)
Adult
(60)
Middle Aged
(54)
Aged
(33)
Biological And Medical Sciences
(32)
Crohn's Disease
(32)
Medical Sciences
(32)
Gastroenterology And Hepatology
(30)
Gastroenterology
(27)
Crohn Disease - Drug Therapy
(26)
Gastroenterology. Liver. Pancreas. Abdomen
(24)
Treatment Outcome
(24)
Infliximab
(23)
Risk Factors
(22)
Ulcerative Colitis
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials

Mesalazine for the treatment of inflammatory bowel disease

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease

Occult hepatitis B and infliximab‐induced HBV reactivation

Could JC virus provoke metastasis in colon cancer?

Is 5-ASA still the treatment of choice for ulcerative colitis?

Gastrointestinal lesions associated with spondyloarthropathies

Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures

Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis

Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: Don't forget the role of cyclosporin

Methodology for high-quality studies on course and prognosis of inflammatory bowel disease

Cytomegalovirus and inflammatory bowel disease: is there a link?

Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome

Anti-interleukin-12 and anti-interleukin-23 agents in Crohn's disease

Randomized controlled trials in perianal Crohn's disease

Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities

Intestinal Permeability and Genetic Determinants in Patients, First-Degree Relatives, and Controls in a High-Incidence Area of Crohn's Disease in Southern Italy

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease

Adalimumab in steroid-dependent Crohnʼs disease patients: Prognostic factors for clinical benefit

Smoking habits and recurrence in Crohn's disease

Suchergebnisse filtern